{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:32:19Z","timestamp":1778279539038,"version":"3.51.4"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Small Animal Practice"],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p><jats:bold>To evaluate the effectiveness of two doses of doxapram in reversing acepromazine sedation in dogs.<\/jats:bold><\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:bold>Using a crossover design, 10 adult mixed\u2010breed dogs received 0\u00b705 mg\/kg acepromazine, intramuscularly (im) followed 30 minutes later by one of the three randomly determined treatments: 0\u00b70625<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\/kg saline, intravenously (iv), 1\u00b725 mg\/kg doxapram, iv or 2\u00b75 mg\/kg doxapram, iv. Sedation scores were obtained by a single, blinded observer at 0, 15 and 30 minutes after acepromazine administration and at 5, 15 and 30 minutes after the treatment administration.<\/jats:bold><\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:bold>The mean baseline sedation score of all the treatments was not different among treatments. All the dogs had a significant increase in sedation score at 30 minutes after acepromazine administration. Both the low and high doses of doxapram showed a significant decrease in sedation score compared to saline, but there was no significant difference between the two doses. Five dogs in the high dose group panted after treatment injection, and this was significantly more than in the low dose group.<\/jats:bold><\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Significance<\/jats:title><jats:p><jats:bold>Doxapram is effective in reducing the sedative effects of acepromazine over a short period of time. A dose of 1\u00b725 mg\/kg effectively decreases acepromazine sedation without causing panting.<\/jats:bold><\/jats:p><\/jats:sec>","DOI":"10.1111\/jsap.12105","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T17:54:58Z","timestamp":1374688498000},"page":"405-408","source":"Crossref","is-referenced-by-count":8,"title":["Refinement of the dose of doxapram to counteract the sedative effects of acepromazine in dogs"],"prefix":"10.1111","volume":"54","author":[{"given":"M.","family":"Zapata","sequence":"first","affiliation":[{"name":"Department of Small Animal Medicine and Surgery, College of Veterinary Medicine University of Georgia Athens GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. H.","family":"Hofmeister","sequence":"additional","affiliation":[{"name":"Department of Small Animal Medicine and Surgery, College of Veterinary Medicine University of Georgia Athens GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.162.26.852"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00568202"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000194289.34345.63"},{"key":"e_1_2_6_5_1","first-page":"103","article-title":"Antagonistic effect of doxapram after rompun treatment in the dog","volume":"2","author":"Dendi J.","year":"1979","journal-title":"Veterinary Medical Review"},{"key":"e_1_2_6_6_1","first-page":"324","article-title":"Electrical changes in CNS produced by a new respiratory stimulant, AHR\u2010619","volume":"21","author":"Funderburk W. H.","year":"1962","journal-title":"Federation Procedings"},{"key":"e_1_2_6_7_1","first-page":"307","volume-title":"Tranquilizers, a\u2010adrenergic agonists and related agents. In: Veterinary Pharmacology and Therapeutics","author":"Gross M. E.","year":"2001"},{"key":"e_1_2_6_8_1","first-page":"396","article-title":"The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs","volume":"99","author":"Hashem A.","year":"1992","journal-title":"Deutsche Tierarztliche Wochenschrift"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2005.226.1092"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.237.10.1155"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/vr.128.14.323"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2002.tb02381.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/jappl.1982.52.5.1261","article-title":"Stimulation of carotid chemoreceptors and ventilation by doxapram in the cat","volume":"52","author":"Nishino T.","year":"1982","journal-title":"Journal of Applied Physiology"},{"key":"e_1_2_6_14_1","first-page":"2","volume-title":"Plumb's Veterinary Drug Handbook","author":"Plumb D. C.","year":"2005"},{"key":"e_1_2_6_15_1","first-page":"2116","article-title":"Antagonism of xylazine\u2010induced depression of shuttle\u2010avoidance responses in dogs by administration of 4\u2010aminopyridine, doxapram or yohimbine","volume":"47","author":"Schaffer D. D.","year":"1986","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_16_1","first-page":"1761","article-title":"Antagonistic effects of Dopram\u2010V on xylazine and acepromazine sedation in dogs","volume":"77","author":"Short C. E.","year":"1982","journal-title":"Veterinary Medicine and Small Animal Clinician"},{"key":"e_1_2_6_17_1","first-page":"191","article-title":"Respiratory, cardiovascular, metabolic and electroencephalographic effects of doxapram hydrochloride in the dog","volume":"28","author":"Soma L. R.","year":"1967","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2460\/ajvr.1995.56.01.78","article-title":"Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs","volume":"56","author":"Stepien R.","year":"1995","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2995.2004.00168.x"}],"container-title":["Journal of Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjsap.12105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjsap.12105","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jsap.12105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T08:02:49Z","timestamp":1715760169000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jsap.12105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.1111\/jsap.12105"],"URL":"https:\/\/doi.org\/10.1111\/jsap.12105","archive":["Portico"],"relation":{},"ISSN":["0022-4510","1748-5827"],"issn-type":[{"value":"0022-4510","type":"print"},{"value":"1748-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]}}}